High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study - Concepedia

Concepedia

Publication | Open Access

High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study

DOI Full Paper Access

117

Citations

9

References

2020

Year

Jesus Loarce‐Martos, Antía García Fernández, F. López-Gutiérrez, V. García García, Laura Calvo-Sanz, Iván del Bosque-Granero, M. Andreína Terán-Tinedo, Alina Boteanu, Javier Bachiller‐Corral, Mónica Vázquez Díaz

Rheumatology International

RheumatologyAutoimmune DiseaseHigh RatesRheumatic DiseasesSevere DiseaseImmunologyInflammatory Rheumatic DiseasePaediatric RheumatologyMedicineCovid-19Rheumatic Disease Patients

References

	Year	Citations

Page 1

Page 1